Upcoming National Audit – Analysis of Prescription Drug Event (PDE) Records for Medical Supplies Associated with the Delivery of Insulin for Beneficiaries with No Evidence of Insulin Use in Medicare Parts B, C, or D

Relevant to: MA-PD, PDPs

The Centers for Medicare & Medicaid Services (CMS), in collaboration with the Plan Program Integrity Medicare Drug Integrity Contractor (PPI MEDIC), will conduct a National Audit of Medicare Part D payments for medical supplies associated with the delivery of insulin for beneficiaries with no evidence of insulin use in Medicare Parts B, C, or D. The National Audit is expected to start February 2024.

See the full guidance for more information.